What are Catalyst Pharmaceutical's profit margins?

Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.

Where do Catalyst Pharmaceutical's ratios come from?

Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Catalyst Pharmaceutical CPRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	86%+0.8pp	85.2%-0.5pp	85.7%-0.1pp	85.8%-0.3pp	86.1%+0.1pp
Operating margin	44.8%+1.1pp	43.8%-1.0pp	44.8%+1.2pp	43.6%+0.3pp	43.3%+3.6pp
Net margin	37.1%+0.7pp	36.4%-1.2pp	37.6%+0.3pp	37.4%+0.4pp	36.9%+3.6pp
EBITDA margin	51.2%+1.0pp	50.2%-1.1pp	51.3%+0.9pp	50.4%0.0pp	50.3%+3.0pp
Free cash flow margin	34.9%-0.6pp	35.4%-5.1pp	40.6%-8.6pp	49.2%-0.9pp	50%+1.4pp
Returns
Return on equity	24.5%-1.0pp	25.5%-2.0pp	27.5%-1.0pp	28.5%-0.6pp	29.1%-0.3pp
Return on assets	21.5%-0.4pp	21.9%-1.9pp	23.9%-1.0pp	24.9%-0.5pp	25.4%+0.6pp
Return on invested capital	83.9%-0.6pp	84.5%-2.1pp	86.6%+2.2pp	84.4%+9.4pp	75%+11.7pp
Efficiency
Asset turnover	0.6×0.0×	0.6×0.0×	0.6×0.0×	0.7×0.0×	0.7×-0.1×
Inventory turnover	3.1×0.0×	3.1×-0.4×	3.4×-0.9×	4.3×+0.6×	3.7×-0.2×
Liquidity
Current ratio	7.1×+1.0×	6.1×-0.5×	6.6×-0.1×	6.7×+0.6×	6.1×+1.0×
Quick ratio	6.8×+1.0×	5.8×-0.6×	6.4×-0.1×	6.5×+0.6×	6×+1.0×
Cash ratio	5.7×+0.9×	4.8×-0.5×	5.4×-0.4×	5.8×+0.6×	5.2×+0.9×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.5×-0.1×	-2.4×-0.1×	-2.3×0.0×	-2.3×-0.2×	-2.1×+0.1×
Per Share
Book value per share	$7.98+6.4%	$7.50+3.6%	$7.24+7.9%	$6.71+7.3%	$6.26+7.4%
Valuation
Market capitalization	$3.02B+5.4%	$2.87B+19.0%	$2.41B-10.4%	$2.69B-8.6%	$2.95B+18.3%
Enterprise value	$2.27B+5.0%	$2.16B+25.4%	$1.72B-15.6%	$2.04B-13.7%	$2.37B+19.9%
Price / earnings	13.7×+0.3×	13.4×+2.3×	11.1×-1.8×	12.9×-2.0×	14.9×-0.3×
Price / sales	5.1×+0.2×	4.9×+0.7×	4.2×-0.7×	4.8×-0.7×	5.5×+0.4×
Price / book	3×0.0×	3×+0.4×	2.6×-0.5×	3.1×-0.6×	3.7×+0.3×
EV / EBITDA	7.4×+0.1×	7.3×+1.5×	5.8×-1.4×	7.3×-1.5×	8.8×+0.3×
EV / sales	3.8×+0.1×	3.7×+0.7×	3×-0.7×	3.7×-0.8×	4.4×+0.4×
Free cash flow yield	6.9%-0.4pp	7.3%-2.5pp	9.7%-0.5pp	10.2%+1.1pp	9.1%-0.5pp
Earnings yield	7.3%-0.2pp	7.5%-1.6pp	9%+1.3pp	7.8%+1.1pp	6.7%+0.1pp
PEG ratio	1.1×+0.7×	0.4×+0.2×	0.2×+0.1×	0.1×0.0×	0.1×0.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Catalyst Pharmaceutical's profit margins?: Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.
Where do Catalyst Pharmaceutical's ratios come from?: Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.